Mateon Therapeutics Announces Termination of FOCUS Study in
Mateon launches antiviral programme focussed on Covid-19
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
EX-4.1
Mateon Therapeutics Archives - IndiaMedToday
Corporate Videos – Oncotelic
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Mateon Therapeutics - BIO Investor Forum | BIO
Mateon and PointR to merge into AI-driven oncology firm
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Zacks Small-Cap Research
EDGAR Filing Documents for 0001493152-21-001207
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
Mateon Therapeutics
Articles about Mateon Therapeutics, Inc.
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
COVID Pandemic Hastens Search For New Technology And CRO Partner
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma
